Tolcher, A. W., Dorff, T. B., Okubo, S., Abraham, L., Reilly, R., Stevenson, C., Wang, S., Cole, A., Mudd, S., Alaei, S., Wang, Y., Quinn, D. I., Saad, F., Powderly, J. D. (2025). Phase 1, open-label, first-in-human study of ABBV-969, a dual variable antibody-drug conjugate, in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps5111